Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-10-23

Clinical Trial Update: Oxytocin and Stress Response in Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxytocin's effect on stress response in individuals with alcohol use disorder; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2019-10-23